Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-02-26
DOI
https://doi.org/10.3389/fonc.2025.1466185
Citations
3
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Robert Díaz Beveridge, Cristina Aguayo, A.J. Cunquero Tomás, Pedro Sánchez Mauriño et al.
3 citations
Frontiers in Oncology
Melanoma and MAPK Pathways
2.42
article

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Robert Díaz Beveridge, Cristina Aguayo, A.J. Cunquero Tomás, Pedro Sánchez Mauriño, Silvia Sequero, Enrique Espinosa, Teresa Puértolas, Pedro Carríón López, Eva Muñoz‐Couselo, Regina García Galindo, Ainara Soria, J.J. Serrano Domingo, Guillermo Crespo, Pablo Miguel, Rafael López Castro, Javier Valdivia, Begoña Campos, Joaquín Fra Rodríguez, Lourdes Gutiérrez Sanz, Pablo Cerezuela‐Fuentes, Lourdes García Sánchez, Gretel Benítez
article en
3 citations

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 15
Hospital Universitario Insular de Gran Canaria (ES), Hospital Universitario La Paz (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital General De Segovia (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital San Pedro de Alcántara (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Universitario Miguel Servet (ES), Hospital Universitario de Burgos (ES), Hospital Universitario Virgen de las Nieves (ES), Complejo Hospitalario de Jaén (ES), Hospital Universitario Reina Sofía (ES), Vall d'Hebron Hospital Universitari (ES), Hospital General Universitario De Valencia (ES), Hospital Universitario Lucus Augusti (ES), Instituto Murciano de Investigación Biosanitaria (ES), Hospital Jerez Puerta del Sur (ES), Hospital Clínico Universitario de Valladolid (ES), Hospital Universitario Río Hortega (ES), Centro de Investigación Biomédica en Red de Cáncer (ES), Hospital Universitario Infanta Sofía (ES), Hospital Universitario Ramón y Cajal (ES), Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 13%
Melanoma and MAPK Pathways
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.